Research & Clinical Development
In the provision of its educational and research services, Hobbs collaborates with many interested parties, including independent and commercial partners, private insurers and other commercial partners, the NHS, charitable organizations, universities, and other academic bodies.
Over its 14-year history, Hobbs has built its industry-leading market position by establishing:
• The largest national independent sector specialist therapy team.
• Close working relationships with NHS/CCGs, 3rd sector as well as independent and insurance markets.
• National recognition for clinical excellence.
• Application of cutting-edge technology within clinical practice.
• Collaborative design and product development processes as a “technology broker for neurorehabilitation” with industry and commercial companies.
• Clinical research programs and collaborations with Winchester, Portsmouth, UWE, Bournemouth, Reading, Imperial College and Southampton Universities.
• Robust relationships with NHS, Fortisnet network, SEHTA and NIHR and NHS England, Innovate UK.
• National links within therapy networks such as INPA, ACPIN, SCIRN and BBTA.
Hobbs at the forefront of Stroke Recovery Research and Development 2020 - 2023
Hobbs is working as part of a multi partner 3 year cross channel project, AiBle, which is being led by the University of Portsmouth.
Hobbs' role is provide the clinical testing and trialling in collaboration with the French team at the Brest University Hospital Centre. We are excited to work in this important role and it is an opportunity for us to bring our own patients to the trial and enable them to use the prototype technology as well as providing much needed data.
We are providing the clinical relevance to the cloud engineering team so that we have the relevant data which will mean that the robot is a meaningful rehabilitation tool. We also are working with the enginneers building the robot to advise on patient specificity; positioning, stability, weight of a typical arm affected by stroke etc.
Because we have a lot of experience working with a vast array of neurotechnology and many devices across a number of years, we are able to add unrivalled value to the project. Our depth and breadth of knowledge as clinicians working with patients using VR games as part of their rehabilitation also enables us to inform the project with real examples and feedback from clinicans and patients which will help in the design of the games themselves, bringing functional relevance and ensuring the games are meaningful and engaging to patients.
Nicky Ellis and Helen Hobbs, Founder-Directors, visit Ability Lab, Chicago
Our Directors recently visited Ability Lab, Chicago USA to explore the specialist neurological rehab, research and technology options. As leaders for clinical excellence in its field, Hobbs is passionate to direct and change the future model of how neurorehabilitation is delivered to improve results and patient outcomes.
Hobbs seeks to take the concept of neurorehabilitation to a new level combining the use of specialist hands-on therapy with cutting edge technology, emerging pharmacology, and stem cell therapy. To this end, Hobbs plans to create a flagship, purpose-built, centre of excellence. This facility will not only deliver clinical excellence but also be a centre for the design and development for innovative cutting-edge technology and clinical research.
Hobbs aims to create a unique environment where engineers, clinicians, and biomedical engineers can work alongside each other to both identify and provide solutions to relevant clinical dilemmas with true patient engagement.
Latest Clinical Development news at Hobbs
Paper published in Frontiers in Neurology, Dec 2020
Frontiers In Neurology is the world's most cited Neuroscience journal: "Rehabilitation Before and After Autologous Haematopoietic Stem Cell Transplantation (AHSCT) for Patients With Multiple Sclerosis (MS)"
Case Study EksoBionics Exoskeleton
Hobbs is a top EksoGT training site and as such is asked by developers to trial and run case studies on the latest in neuro technology. Read the Case Study here
Effects of robotic-assisted gait training on the central vascular health of individuals with spinal cord injury: A pilot study
Ectron Limited joined us for a day at MINT (Masterclass In Neuro Technology), a milestone in our clinical education offering. The Pablo Tyrosolution for upper limb and the Eksobionic Exoskeleton for lower limb. A full exploration of their use in clinical practice was enjoyed by all (see photos below)
Hobbs Rehabilitation is part of a Specialist Clinical Independent Rehabilitation Network (SCIRN). Working with the Police, Fire Brigade, Armed Services and Injured Jockey Fund. This Specialist Group is sharing good practice for rehabilitation and writing
clinical guidelines for best practice. Hobbs is the clinical lead for neurorehabilitation within the group.
The forum is an arena where specialist rehabilitation organisations can:
- Establish and improve clinical standards
- Share common issues and support each other with problem solving
- Provide peer support and review
- Share, skills, knowledge and information
- Create opportunities for staff and service development
By focussing on each patient's physical, psychological, and environmental needs a well managed rehabilitation program can often reverse many disabling conditions, thus helping patients cope with deficits which cannot be reversed by medical care alone.
We are working with BUPA to offer intensive rehabilitation packages within the community setting. This is a new initiative, the goal is for Hobbs to develop a national network of specialist providers. The providers will be affiliated to Hobbs ensuring a quality service.
We have a LiteGait trainer based in Winchester with a fully trained therapy team and we have recently agreed to run National training courses.
We are also the clinical lead for the AlterG Bionic Leg in the UK and Europe and are providing a National training service for this too.
We have links with Winchester and Southampton Universities and are currently working with an American company in collaboration with the NHS to research the use of the bionic leg in both the acute hospital setting, the sub acute rehabilitation setting and the more long term community benefits. Additionally, we are hoping to achieve Nice guidelines approval soon.
We are also designing a protocol for a PhD study on the Eksobionics skeleton.